Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIA 5-453 SAD study in healthy volunteers
NCT02845037Phase 1Completed
- Sponsor
- BIAL
- Start
- May 2007
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of etamicastat in hypertension (HTN) and chronic heart failure (CHF) (10 arms), sponsored by BIAL. Primary endpoints: Maximum observed plasma concentration, Time to reach Cmax and 5 more. Started May 2007; status: completed.
02
Drugs
etamicastat
03
Conditions
hypertension (HTN)chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT02845037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845037.